|
1
|
Ghaderi L, Montazer M and Naseri AR:
Association of two high-risk strains of human papillomavirus (HPV18
and HPV16) with breast cancer in the patients using polymerase
chain reaction. J Res Clin Med. 10:122022. View Article : Google Scholar
|
|
2
|
Oliveira ES, de Ferreira MVP, Rahal P,
Castelo Branco MB and Rabenhorst SHB: High Frequency of
Epstein-Barr Virus and Absence of Papillomavirus in Breast Cancer
Patients from Brazilian Northeast. Asian Pac J Cancer Prev.
23:2351–2359. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maldonado-Rodríguez E, Hernández-Barrales
M, Reyes-López A, Mendoza-Almanza G and Ayala-Luján JL,
Godina-González S, Gallegos-Flores PI, Esparza-Ibarra EL,
González-Curiel IE, Aguayo-Rojas J, López-Saucedo A,
Mendoza-Almanza G and Ayala-Luján JL: Presence of human
papillomavirus DNA in malignant Neoplasia and Non-malignant breast
disease. Curr Issues Mol Biol. 44:3648–3665. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Golrokh Mofrad M, Sadigh ZA, Ainechi S and
Faghihloo E: Detection of human papillomavirus genotypes, herpes
simplex, varicella zoster and cytomegalovirus in breast cancer
patients. Virol J. 18:252021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sher G, Salman NA, Kulinski M, Fadel RA,
Gupta VK, Anand A, Gehani S, Abayazeed S, Al-Yahri O, Shahid F, et
al: Prevalence and type distribution of high-risk human
papillomavirus (HPV) in breast cancer: A Qatar based study. Cancers
(Basel). 12:15282020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alinezhadi M, Makvandi M, Kaydani GA,
Jazayeri SN, Charostad J, Talaiezadeh A and Angali KA: Detection of
high-risk human papillomavirus DNA in invasive ductal carcinoma
specimens. Asian Pac J Cancer Prev. 23:3201–3207. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gupta I, Ulamec M, Peric-Balja M, Ramic S,
Al Moustafa AE, Vranic S and Al-Farsi HF: Presence of high-risk
HPVs, EBV, and MMTV in human triple-negative breast cancer. Hum
Vaccin Immunother. 17:4457–4466. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Silva RG and Da Silva BB: No evidence for
an association of human papillomavirus and breast carcinoma. Breast
Cancer Res Treat. 125:261–264. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Herrera-Goepfert R, Khan NA, Koriyama C,
Akiba S and Pérez-Sánchez VM: High-risk human papillomavirus in
mammary gland carcinomas and non-neoplastic tissues of Mexican
women: No evidence supporting a cause and effect relationship.
Breast. 20:184–189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Alibek K, Kakpenova A, Mussabekova A,
Sypabekova M and Karatayeva N: Role of viruses in the development
of breast cancer. Infect Agent Cancer. 8:322013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gebregzabher E, Seifu D, Tigneh W,
Bokretsion Y, Bekele A, Abebe M, Lillsunde-Larsson G, Karlsson C
and Karlsson MG: Detection of High-And Low-Risk HPV DNA in archived
breast carcinoma tissues from Ethiopian women. Int J Breast Cancer.
2021:21401512021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aghdam MK, Nadji SA, Alvandimanesh A,
Khoddami M and Khademi Y: Absence of human Papillomavirus in benign
and malignant breast tissue. Iran J Pathol. 14:279–283. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Corbex M, Bouzbid S, Traverse-Glehen A,
Aouras H, McKay-Chopin S, Carreira C, Lankar A, Tommasino M and
Gheit T: Prevalence of papillomaviruses, polyomaviruses, and
herpesviruses in triple-negative and inflammatory breast tumors
from Algeria compared with other types of breast cancer tumors.
PLoS One. 9:e1145592014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li N, Bi X, Zhang Y, Zhao P, Zheng T and
Dai M: Human papillomavirus infection and sporadic breast carcinoma
risk: A meta-analysis. Breast Cancer Res Treat. 126:515–520. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Di Lonardo A, Venuti A and Marcante ML:
Human papillomavirus in breast cancer. Breast Cancer Res Treat.
21:95–100. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mastoraki A, Schizas D, Gkiala A, Ntella
V, Hasemaki N, Pentara I, Ntomi V, Kapelouzou A and Liakakos T:
Human Papilloma Virus infection and breast cancer development:
Challenging theories and controversies with regard to their
potential association. J BUON. 25:1295–1301. 2020.PubMed/NCBI
|
|
18
|
Mou X, Chen L, Liu F, Shen Y, Wang H, Li
Y, Yuan L, Lin J, Lin J, Teng L and Xiang C: Low prevalence of
human papillomavirus (HPV) in Chinese patients with breast cancer.
J Int Med Res. 39:1636–1644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo H, Idrovo JP, Cao J, Roychoudhury S,
Navale P, Auguste LJ, Bhuiya T and Sheikh-Fayyaz S: Human
Papillomavirus (HPV) detection by chromogenic in situ hybridization
(CISH) and p16 immunohistochemistry (IHC) in breast intraductal
papilloma and breast carcinoma. Clin Breast Cancer. 21:e638–e646.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Calderon G, Castaneda CA, Castillo M,
Sanchez J, Bernabe L, Suarez N, Tello K, Torres E, Cotrina JM,
Dunstan J, et al: Human papillomavirus, cytomegalovirus infection
and P16 staining in breast tumors from Peruvian women. Asian Pac J
Cancer Prev. 23:1571–1576. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Delgado-García S, Martínez-Escoriza JC,
Alba A, Martín-Bayón TA, Ballester-Galiana H, Peiró G, Caballero P
and Ponce-Lorenzo J: Presence of human papillomavirus DNA in breast
cancer: A Spanish case-control study. BMC Cancer. 17:3202017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Clark J, Glasziou P, Del Mar C,
Bannach-Brown A, Stehlik P and Scott AM: A full systematic review
was completed in 2 weeks using automation tools: A case study. J
Clin Epidemiol. 121:81–90. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. Syst Rev. 10:892021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Critical Appraisal Skills Programme
(CASP), . Case-Control Study Checklist. 2022.
|
|
25
|
Cochrane Handbook for Systematic Reviews
of Interventions, . Available from. https://training.cochrane.org/handbook/current
|
|
26
|
Mostafaei S, Kazemnejad A, Norooznezhad
AH, Mahaki B and Moghoofei M: Simultaneous effects of viral factors
of human papilloma virus and Epstein-Barr virus on progression of
breast and thyroid cancers: Application of structural equation
modeling. Asian Pac J Cancer Prev. 21:1431–1439. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oramas DM, Bell D and Middleton LP:
Sinonasal analogue HPV related breast multiphenotypic carcinoma, a
report of a case with the first description in the breast. Diagn
Pathol. 15:1372020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Balci FL, Uras C and Feldman SM: Is human
papillomavirus associated with breast cancer or papilloma
presenting with pathologic nipple discharge? Cancer Treat Res
Commun. 19:1001222019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baltzell KA, Shen HM, Krishnamurthy S,
Sison JD, Nuovo GJ and Buehring GC: Bovine leukemia virus linked to
breast cancer but not coinfection with human papillomavirus:
Case-control study of women in Texas. Cancer. 124:1342–1349. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kouloura A, Nicolaidou E, Misitzis I,
Panotopoulou E, Theodoraki K, Smyrniotis V, Corso G, Veronesi P and
Arkadopoulos N: HPV infection and breast cancer. Results of a
microarray approach. Breast. 40:165–169. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ghaffari H, Nafissi N, Hashemi-Bahremani
M, Alebouyeh MR, Tavakoli A, Javanmard D, Bokharaei-Salim F,
Mortazavi HS and Monavari SH: Molecular prevalence of human
papillomavirus infection among Iranian women with breast cancer.
Breast Dis. 37:207–213. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang YW, Zhang K, Zhao S, Lv Y, Zhu J, Liu
H, Feng J, Liang W, Ma R and Wang J: HPV Status and Its Correlation
with BCL2, p21, p53, Rb, and survivin expression in breast cancer
in a Chinese Population. Biomed Res Int. 2017:63153922017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang YX, Li YZ, Zhang ZY, Wang JQ, Cui J
and Qian XL: HPV16 E6 promotes breast cancer proliferation via
upregulation of COX-2 expression. Biomed Res Int. 2017:29484672017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rezaei H, Rassi H and Mansur FN:
Investigation of Methylenetetrahydrofolate Reductase C677T
polymorphism and human papilloma virus genotypes in Iranian breast
cancer. Monoclon Antib Immunodiagn Immunother. 36:124–128. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Naushad W, Surriya O and Sadia H:
Prevalence of EBV, HPV and MMTV in Pakistani breast cancer
patients: A possible etiological role of viruses in breast cancer.
Infect Genet Evol. 54:230–237. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Islam S, Dasgupta H, Roychowdhury A,
Bhattacharya R, Mukherjee N, Roy A, Mandal GK, Alam N, Biswas J,
Mandal S, et al: High-risk human papillomavirus in mammary gland
carcinomas and non-neoplastic tissues of Mexican women: No evidence
supporting a cause and effect relationship: Study of association
and molecular analysis of human papillomavirus in breast cancer of
Indian patients: Clinical and prognostic implication. PLoS One.
12:e01727602017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Atique S, Hsieh CH, Hsiao RT, Iqbal U,
Nguyen PAA, Islam MM, Li YJ, Hsu CY, Chuang TW and Syed-Abdul S:
Viral warts (Human Papilloma Virus) as a potential risk for breast
cancer among younger females. Comput Methods Programs Biomed.
144:203–207. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tsuboi M, Yamane A, Horiguchi J, Yokobori
T, Kawabata-Iwakawa R, Yoshiyama S, Rokudai S, Odawara H, Tokiniwa
H, Oyama T, et al: APOBEC3B high expression status is associated
with aggressive phenotype in Japanese breast cancers. Breast
Cancer. 23:780–788. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Søgaard M, Farkas DK, Ording AG, Sørensen
HT and Cronin-Fenton DP: Conisation as a marker of persistent human
papilloma virus infection and risk of breast cancer. Br J Cancer.
115:588–591. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mohtasebi P, Rassi H, Maleki F,
Hajimohammadi S, Bagheri Z, Fakhar Miandoab M and Naserbakht M:
Detection of human papillomavirus genotypes and major BRCA
mutations in familial breast cancer. Monoclon Antib Immunodiagn
Immunother. 35:135–140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ehsan Ilahi N, Anwar S, Noreen M, Naiyar
Hashmi S and Murad S: Detection of human papillomavirus-16 DNA in
archived clinical samples of breast and lung cancer patients from
North Pakistan. J Cancer Res Clin Oncol. 142:2497–2502. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang D, Fu L, Shah W, Zhang J, Yan Y, Ge
X, He J, Wang Y and Li X: Presence of high-risk HPV DNA but
indolent transcription of E6/E7 oncogenes in invasive ductal
carcinoma of breast. Pathol Res Pract. 212:1151–1156. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yan C, Teng ZP, Chen YX, Shen DH, Li JT
and Zeng Y: Viral etiology relationship between human
papillomavirus and human breast cancer and target of gene therapy.
Biomed Environ Sci. 29:331–339. 2016.PubMed/NCBI
|
|
44
|
El-Shinawi M, Mohamed HT, Abdel-Fattah HH,
Ibrahim SA, El-Halawany MS, Nouh MA, Schneider RJ and Mohamed MM:
Inflammatory and Non-inflammatory Breast Cancer: A potential role
for detection of multiple viral DNAs in disease progression. Ann
Surg Oncol. 23:494–502. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fimereli D, Gacquer D, Fumagalli D,
Salgado R, Rothé F, Larsimont D, Sotiriou C and Detours V: No
significant viral transcription detected in whole breast cancer
transcriptomes. BMC Cancer. 15:1472015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ali SH, Al-Alwan NA and Al-Alwany SH:
Detection and genotyping of human papillomavirus in breast cancer
tissues from Iraqi patients. East Mediterr Health J. 20:372–377.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Piana AF, Sotgiu G, Muroni MR, Cossu-Rocca
P, Castiglia P and De Miglio MR: HPV infection and triple-negative
breast cancers: An Italian case-control study. Virol J. 11:902014.
View Article : Google Scholar
|
|
48
|
Ohba K, Ichiyama K, Yajima M, Gemma N,
Nikaido M, Wu Q, Chong P, Mori S, Yamamoto R, Wong JE and Yamamoto
N: In vivo and in vitro studies suggest a possible involvement of
HPV infection in the early stage of breast carcinogenesis via
APOBEC3B induction. PLoS One. 9:e977872014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hong L and Tang S: Does HPV 16/18
infection affect p53 expression in invasive ductal carcinoma? An
experimental study. Pak J Med Sci. 30:789–792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liang W, Wang J, Wang C, Lv Y, Gao H,
Zhang K, Liu H, Feng J, Wang L and Ma R: Detection of high-risk
human papillomaviruses in fresh breast cancer samples using the
hybrid capture 2 assays. J Med Virol. 85:2087–2092. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Herrera-Goepfert R, Vela-Chávez T,
Carrillo-García A, Lizano-Soberón M, Amador-Molina A, Oñate-Ocaña
LF and Hallmann RSR: High-risk human papillomavirus (HPV) DNA
sequences in metaplastic breast carcinomas of Mexican women. BMC
Cancer. 13:4452013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pereira Suarez AL, Lorenzetti MA, Gonzalez
Lucano R, Cohen M, Gass H, Martinez Vazquez P, Gonzalez P, Preciado
MV and Chabay P: Presence of human papilloma virus in a series of
breast carcinoma from argentina. PLoS One. 8:e616132013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hossein R, Behzad S, Tahar M and Azadeh
NA: Prevalence of human papillomavirus genotypes associated with
cervical and breast cancers in Iran. Monoclon Antib Immunodiagn
Immunother. 32:399–403. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Herrera-Romano L, Fernández-Tamayo N,
Gómez-Conde E, Reyes-Cardoso JM, Ortiz-Gutierrez F, Ceballos G,
Valdivia A, Piña P and Salcedo M: Absence of human papillomavirus
sequences in epithelial breast cancer in a Mexican female
population. Med Oncol. 29:1515–1517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hansen BT, Nygård M, Falk RS and Hofvind
S: Breast cancer and ductal carcinoma in situ among women with
prior squamous or glandular precancer in the cervix: A
register-based study. Br J Cancer. 107:1451–1453. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Glenn WK, Heng B, Delprado W, Iacopetta B,
Whitaker NJ and Lawson JS: Epstein-Barr virus, human papillomavirus
and mouse mammary tumour virus as multiple viruses in breast
cancer. PLoS One. 7:e487882012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Baltzell K, Buehring GC, Krishnamurthy S,
Kuerer H, Shen HM and Sison JD: Limited evidence of human
papillomavirus on breast tissue using molecular in situ methods.
Cancer. 118:1212–1220. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hedau S, Kumar U, Hussain S, Shukla S,
Pande S, Jain N, Tyagi A, Deshpande T, Bhat D, Mir MM, et al:
Breast cancer and human papillomavirus infection: No evidence of
HPV etiology of breast cancer in Indian women. BMC Cancer.
11:272011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Khammapirad T, Prueksadee J, Diaz-Arrastia
C, Botting SK, Leonard M, Bonoan-Deomampo L and Eltorky MA:
Intraductal papilloma of the breast in association with
preoncogenic gene of breast cancer. Asian Pac J Trop Biomed.
1:161–163. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cazzaniga M, Gheit T, Casadio C, Khan N,
Macis D, Valenti F, Miller MJ, Sylla BS, Akiba S, Bonanni B, et al:
Analysis of the presence of cutaneous and mucosal papillomavirus
types in ductal lavage fluid, milk and colostrum to evaluate its
role in breast carcinogenesis. Breast Cancer Res Treat.
114:599–605. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Fan CL, Zhou JH and Hu CY: Expression of
human papillomavirus in mammary carcinoma and its possible
mechanism in carcinogenesis. Virol Sin. 23:226–231. 2008.
View Article : Google Scholar
|
|
62
|
Akil N, Yasmeen A, Kassab A, Ghabreau L,
Darnel AD and Al Moustafa AE: High-risk human papillomavirus
infections in breast cancer in Syrian women and their association
with Id-1 expression: A tissue microarray study. Br J Cancer.
99:404–407. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Liang W and Tian H: Hypothetic association
between human papillomavirus infection and breast carcinoma. Med
Hypotheses. 70:305–307. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Duò D, Ghimenti C, Migliora P, Pavanelli
MC, Mastracci L and Angeli G: Identification and characterization
of human papillomavirus DNA sequences in Italian breast cancer
patients by PCR and line probe assay reverse hybridization. Mol Med
Rep. 1:673–677. 2008.PubMed/NCBI
|
|
65
|
De Cremoux P, Thioux M, Lebigot I,
Sigal-Zafrani B, Salmon R and Sastre-Garau X: No evidence of Human
papillomavirus DNA sequences in invasive breast carcinoma. Breast
Cancer Res Treat. 109:55–58. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Choi YL, Cho EY, Kim JH, Nam SJ, Oh YL,
Song SY, Yang JH and Kim DS: Detection of human papillomavirus DNA
by DNA chip in breast carcinomas of Korean women. Tumor Biol.
28:327–332. 2007. View Article : Google Scholar
|
|
67
|
Yasmeen A, Bismar TA, Dekhil H, Ricciardi
R, Kassab A, Gambacorti-Passerini C and Moustafa AE Al: ErbB-2
receptor cooperates with E6/E7 oncoproteins of HPV type 16 in
breast tumorigenesis. Cell Cycle. 6:2939–2943. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Yasmeen A, Bismar TA, Kandouz M, Foulkes
WD, Desprez PY and Al Moustafa AE: E6/E7 of HPV type 16 promotes
cell invasion and metastasisof human breast cancer cells. Cell
Cycle. 6:2038–2042. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Lindel K, Forster A, Altermatt HJ, Greiner
R and Gruber G: Breast cancer and human papillomavirus (HPV)
infection: No evidence of a viral etiology in a group of Swiss
women. Breast. 16:172–177. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kroupis C, Markou A, Vourlidis N,
Dionyssiou-Asteriou A and Lianidou ES: Presence of high-risk human
papillomavirus sequences in breast cancer tissues and association
with histopathological characteristics. Clin Biochem. 39:727–731.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Tsai JH, Tsai CH, Cheng MH, Lin SJ, Xu FL
and Yang CC: Association of viral factors with non-familial breast
cancer in Taiwan by comparison with non-cancerous, fibroadenoma,
and thyroid tumor tissues. J Med Virol. 75:276–281. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
de Villiers E-M, Sandstrom RE, zur Hausen
H and Buck CE: Presence of papillomavirus sequences in
condylomatous lesions of the mamillae and in invasive carcinoma of
the breast. Breast Cancer Res. 7:R1–R11. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Widschwendter A, Brunhuber T, Wiedemair A,
Mueller-Holzner E and Marth C: Detection of human papillomavirus
DNA in breast cancer of patients with cervical cancer history. J
Clin Virol. 31:292–297. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Afshar RM, Balar N, Mollaei HR, Arabzadeh
SA and Iranpour M: Low prevalence of human papilloma virus in
patients with breast cancer, Kerman; Iran. Asian Pac J Cancer Prev.
19:3039–3044. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ahangar-Oskouee M, Shahmahmoodi S,
Jalilvand S, Mahmoodi M, Ziaee AA, Esmaeili HA, Keshtvarz M,
Pishraft-Sabet L, Yousefi M, Mollaei-Kandelous Y, et al: No
detection of ‘High-risk’ human papillomaviruses in a group of
Iranian women with breast cancer. Asian Pac J Cancer Prev.
15:4061–4065. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Antonsson A, Spurr TP, Chen AC, Francis
GD, McMillan NA, Saunders NA, Law M and Bennett IC: High prevalence
of human papillomaviruses in fresh frozen breast cancer samples. J
Med Virol. 83:2157–2163. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bakhtiyrizadeh S, Hosseini SY, Yaghobi R,
Safaei A and Sarvari J: Almost complete lack of human
cytomegalovirus and human papillomaviruses genome in benign and
malignant breast lesions in Shiraz, Southwest of Iran. Asian Pac J
Cancer Prev. 18:3319–3324. 2017.PubMed/NCBI
|
|
78
|
Cavalcante JR, Pinheiro LGP, de Almeida
PRC, Ferreira MVP, Cruz GA, Campelo TA, Silva CS, Lima LNGC,
Oliveira BMK, Lima LM, et al: Association of breast cancer with
human papillomavirus (HPV) infection in northeast brazil: Molecular
evidence. Clinics. 73:6–11. 2018. View Article : Google Scholar
|
|
79
|
Chang P, Wang T, Yao Q, Lv Y, Zhang J, Guo
W, Wang L and Chen J: Absence of human papillomavirus in patients
with breast cancer in north-west China. Med Oncol. 29:521–525.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Damin AP, Karam R, Zettler CG, Caleffi M
and Alexandre CO: Evidence for an Association of human
papillomavirus and breast carcinomas. Breast Cancer Res Treat.
84:131–137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
de León DC, Montiel DP, Nemcova J,
Mykyskova I, Turcios E, Villavicencio V, Cetina L, Coronel A and
Hes O: Human papillomavirus (HPV) in breast tumors: prevalence in a
group of Mexican patients. BMC Cancer. 9:262009. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Doosti M, Bakhshesh M, Zahir ST,
Shayestehpour M and Karimi-Zarchi M: Lack of evidence for a
relationship between high risk human papillomaviruses and breast
cancer in Iranian patients. Asian Pac J Cancer Prev. 17:4357–4361.
2016.PubMed/NCBI
|
|
83
|
ElAmrani A, Gheit T, Benhessou M,
McKay-Chopin S, Attaleb M, Sahraoui S, El Mzibri M, Corbex M,
Tommasino M and Khyatti M: Prevalence of mucosal and cutaneous
human papillomavirus in Moroccan breast cancer. Papillomavirus Res.
5:150–155. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Fu L, Wang D, Shah W, Wang Y, Zhang G and
He J: Association of human papillomavirus type 58 with breast
cancer in Shaanxi province of China. J Med Virol. 87:1034–1040.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Gannon OM, Antonsson A, Milevskiy M, Brown
MA, Saunders NA and Bennett IC: No association between HPV positive
breast cancer and expression of human papilloma viral transcripts.
Sci Rep. 5:180812015. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Li J, Ding J and Zhai K: Detection of
human papillomavirus DNA in patients with breast tumor in China.
PLoS One. 10:e01360502015. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Mendizabal-Ruiz AP, Morales JA,
Ramírez-Jirano LJ, Padilla-Rosas M, Morán-Moguel MC and
Montoya-Fuentes H: Low frequency of human papillomavirus DNA in
breast cancer tissue. Breast Cancer Res Treat. 114:189–194. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Salman NA, Davies G, Majidy F, Shakir F,
Akinrinade H, Perumal D and Ashrafi GH: Association of high-risk
human papillomavirus and breast cancer: A UK based Study. Sci Rep.
7:435912017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Sigaroodi A, Nadji SA, Naghshvar F, Nategh
R, Emami H and Velayati AA: Human papillomavirus is associated with
breast cancer in the north part of Iran. ScientificWorldJournal.
2012:8371912012. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Tawfeik AM, Mora A, Osman A, Moneer MM,
El-Sheikh N and Elrefaei M: Frequency of CD4+ regulatory T cells,
CD8+ T cells, and human papilloma virus infection in Egyptian Women
with breast cancer. Int J Immunopathol Pharmacol.
34:20587384209668222020. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Vernet-Tomas M, Mena M, Alemany L, Bravo
I, De Sanjosé S, Nicolau P, Bergueiro A, Corominas JM, Serrano S,
Carreras R and Lloveras B: Human papillomavirus and breast cancer:
No evidence of association in a Spanish set of cases. Anticancer
Res. 35:851–856. 2015.PubMed/NCBI
|
|
92
|
Wang T, Zeng X, Li W, Zhu H, Wang G, Liu
X, Lv Y, Wu J, Zhuang X, Zhang J, et al: Detection and analysis of
human papillomavirus (HPV) DNA in breast cancer patients by an
effective method of HPV capture. PLoS One. 9:e903432014. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Tufanaru C, Munn Z, Stephenson M and
Aromataris E: Fixed or random effects meta-analysis? Common
methodological issues in systematic reviews of effectiveness. Int J
Evid Based Healthc. 13:196–207. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Gupta I, Jabeen A, Al-Sarraf R, Farghaly
H, Vranic S, Sultan AA, Al Moustafa AE and Al-Thawadi H: The
co-presence of high-risk human papillomaviruses and Epstein-Barr
virus is linked with tumor grade and stage in Qatari women with
breast cancer. Hum Vaccin Immunother. 17:982–989. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Nagi K, Gupta I, Jurdi N, Jabeen A,
Yasmeen A, Batist G, Vranic S and Al-Moustafa AE: High-risk human
papillomaviruses and Epstein-Barr virus in breast cancer in
Lebanese women and their association with tumor grade: A molecular
and tissue microarray study. Cancer Cell Int. 21:3082021.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Habyarimana T, Attaleb M, Mazarati JB,
Bakri Y and El Mzibri M: Detection of human papillomavirus DNA in
tumors from Rwandese breast cancer patients. Breast Cancer.
25:127–133. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Bønløkke S, Blaakær J, Steiniche T,
Høgdall E, Jensen SG, Hammer A, Balslev E, Strube ML, Knakkergaard
H and Lenz S: Evidence of no association between human
papillomavirus and breast cancer. Front Oncol. 8:2092018.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Gupta I, Al-Sarraf R, Farghaly H, Vranic
S, Sultan AA, Al-Thawadi H, Al Moustafa AE and Al-Farsi HF:
Incidence of HPVs, EBV, and MMTV-Like Virus in Breast Cancer in
Qatar. Intervirology. 65:188–194. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Favere K, Menon S, Valentine K, Bogers J
and Vanden Broeck D: Human papillomavirus prevalence and breast
carcinogenesis: A systematic review and meta-analysis of published
literature. Eur J Gynaecol Oncol. 39:160–173. 2018.
|
|
100
|
Simões PW, Medeiros LR, Simões Pires PD,
Edelweiss MI, Rosa DD, Silva FR, Silva BR and Rosa MI: Prevalence
of human papillomavirus in breast cancer: A systematic review. Int
J Gynecol Cancer. 22:343–347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Jalilvand S, Shoja Z and Hamkar R: Human
papillomavirus burden in different cancers in Iran: A systematic
assessment. Asian Pac J Cancer Prev. 15:7029–7035. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Sokal DC, Vach TH, Nanda K, McCann MF,
Weiner DH, Drobnes C, Rochanawutanon M, Duc NB and Loan ND:
Quinacrine sterilization and gynecologic cancers: A case-control
study in northern Vietnam. Epidemiology. 21:164–171. 2010.
View Article : Google Scholar : PubMed/NCBI
|
